Landscapes / Companies
Ellipses Pharma not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
4 in Phase 2
Drugs
4
in active trials · 5 in all
Trials
4 active
6 since 2021
Drugs4
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | Mar 2027Phase 1/2 trial completes | |||
| Next date | Mar 2027 · Phase 1/2 trial completes | ||||
| Also tested for | NSCLC | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2027Phase 1/2 trial completes | |||
| Next date | Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Feb 2028Phase 1/2 trial completes | |||
| Next date | Feb 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Mar 2028Phase 1/2 trial completes | |||
| Next date | Mar 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Solid Cancers, Solid Tumours | ||||
| Open drug page | |||||
About
- No active trial
- EP0057
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021